Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis

References

• World Health Organization. WHO Expert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser 2013;982:1-139
   Web of Science ®Google Scholar
• World Health Organization. Rabies vaccine: WHO position paper. Weekly Epidemiol Rec 2010;85:309-20
   Google Scholar
• Briggs DJ. The role of vaccination in rabies prevention. Curr Opinion Virol 2012;2:309-14
   PubMed Web of Science ®Google Scholar
• Chutivongse S, Wilde H, Supish C, et al. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990;1:896-8
   Web of Science ®Google Scholar
• Briggs DJ, Banzhoff A, Nicolay U, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000;78(5):693-8
   PubMed Web of Science ®Google Scholar
• Khawplod P, Wilde H, Sirikwin S, et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006;24(16):3084-6
   PubMed Web of Science ®Google Scholar
• Quiambao BP, Dy-Tioco HZ, Dizon RM, et al. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines. Vaccine 2009;27:7162-6
   PubMed Web of Science ®Google Scholar
• Toovey S. Preventing rabies with the Verorab® vaccine: 1985–2005: Twenty years of clinical experience. J Travel Med Infect Dis 2007;5:327-48
   PubMedGoogle Scholar
• Quiambao BP, Lang J, Vital S, et al. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomized clinical trial in the Philippines. Acta Trop 2000;75:39-52
   PubMed Web of Science ®Google Scholar
• Jones RL, Froeschle JE, Atmar RL, et al. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 2001;19:4635-43
   PubMed Web of Science ®Google Scholar
• Arora A, Moeller L, Froeschle J. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine. J Travel Med 2004;11:195-200
   PubMed Web of Science ®Google Scholar
• Picot’ N, LeMeneti V, Rotive Y, et al. Booster effect of a new chromatographically purified Vero cell rabies vaccine (CPRV):immunogenicity and safety of a single or double injection. Trans R Soc Trop Med Hyg 2001;95:242-4
   Web of Science ®Google Scholar
• Wang C, Zhang X, Song Q, Tang K. Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified Vero cell vaccine produced in China. Clin Vaccine Immunol 2010;17(4):688-90
   PubMedGoogle Scholar
• Ling-yun W, Mei-ping S, Xue-chun Z, et al. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis. Vaccine 2011;29:2679-81
   PubMed Web of Science ®Google Scholar
• Sabchareon A, Chantavanich P, Pasuralertsakul S, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998;17:1001-7
   PubMed Web of Science ®Google Scholar
• Phanuphak P, Khawplod P, Sirivichayakul S, et al. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac J Allergy Immunol 1987;5(1):33-7
   PubMed Web of Science ®Google Scholar
• Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973;48:535-41
   PubMed Web of Science ®Google Scholar
• Crowle AJ, Atkins A, May M. Induction of delayed hypersensitivity to protein antigens in mice without Freund’s adjuvants. J Allergy Clin Immunol 1977;60:14-26
   PubMed Web of Science ®Google Scholar
• Warell MJ, Warell DA, Suntharsamai P, et al. An economical regimen of human diploid cell strain rabies vaccine for post-exposure prophylaxis. Lancet 1983;2(8345):301-4
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Suntharasamai P, Nicholson KG, et al. Multi-site intradermal and multisite subcutaneous rabies vaccination: improved economical regimens. Lancet 1984;1(8382):874-6
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Warrell DA. Intradermal regimens for rabies postexposure prophylaxis: more confusion. Clin Infect Dis 2002;35:213-14
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Sanjay TV, Mahendra BJ, et al. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1ml. Hum Vaccin 2006;2(5):200-4
   PubMed Web of Science ®Google Scholar
• Tantawichien T, Benjawongkulchai M, Limsuwan K, et al. Antibody response after a 4-site intradermal booster with cell-culture rabies vaccine. Clin Infect Dis 1999;28(5):1110-12
   Web of Science ®Google Scholar
• Tantawichien T, Tantawichien T, Supit C, et al. Three-year experience of a four-site intradermal booster vaccination with cell-culture rabies vaccine for post-exposure prophylaxis. Clin Infect Dis 2001;33:2085-7
   PubMed Web of Science ®Google Scholar
• The Asian Rabies Expert Bureau. Report of the sixth AREB meeting. Vaccine 2010;28:3265-8
   PubMedGoogle Scholar
• Suwansrinon K, Wilde H, Benjavongkulchai M, et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006;24:3878-80
   PubMed Web of Science ®Google Scholar
• Thraenhart O, Kreuzfelder E, Hillebrandt M, et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 1994;71(3):287-92
   PubMedGoogle Scholar
• Sood SK. Immunization for children traveling aboard. Pediatr Clin North Am 2000;47(2):435-48
   PubMed Web of Science ®Google Scholar
• Piyaphanee W, Shantavasinkul P, Phumratanaprapin W, et al. Rabies exposure risk among foreign backpackers in southeast Asia. Am J Trop Med Hyg 2010;82(6):1168-71
   PubMed Web of Science ®Google Scholar
• Goswami A, Plun-Favreau J, Nicoloyannis N, et al. The real cost of rabies post-exposure treatments. Vaccine 2005;23:2970-6
   PubMed Web of Science ®Google Scholar
• Verma R, Khanna P, Prinja S, Rajput M. Intra-dermal administration of rabies vaccines in developing countries. Human Vaccin 2011;7(7):792-4
   PubMed Web of Science ®Google Scholar
• Yu P, Huang Y, Zhang Y, et al. Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology. Human Vaccin Immunother 2012;8(9):1230-5
   PubMed Web of Science ®Google Scholar
• Liu H, Huang G, Tang Q, et al. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Human Vaccin 2011;7:220-4
   PubMed Web of Science ®Google Scholar
• Frazzati-Gallina NM, Paoli RL, Moura˜o-Fuches RM, et al. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. J Biotechnol 2001;92:67-72
   PubMed Web of Science ®Google Scholar
• Trabelsi K, Rourou S, Loukil H, et al. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J Biotechnol 2006;121:261-71
   PubMed Web of Science ®Google Scholar
• Rourou S, Ark A, Velden T, Kallel H. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 2007;25:3879-89
   PubMed Web of Science ®Google Scholar
• Strady A, Lang J, Lienard M, et al. Antibody persistence following pre-exposure regimens of cell-culture rabies vaccine. J Infect Dis 1998;177:1290-5
   PubMed Web of Science ®Google Scholar
• Kositprara C, Limsuwan K, Wilde H, et al. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin Infect Dis 1997;25:614-15
   PubMed Web of Science ®Google Scholar
• Kamoltham T, Thinyounyong W, Phongchamnaphai P, et al. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe. J Pediatr 2007;151(2):173-7
   PubMed Web of Science ®Google Scholar
• Vien NG, Feroldi E, Lang J. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans Royal Soc Trop Med Hyg 2008;102:294-6
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee on biological standardization. World Health Organ Tech Rep Ser 2007(941):1-340
   Google Scholar
• Zoonoses control: WHO consultation on intradermal application of human rabies vaccines. Wkly Epidemiol Rec 1995;70:336-8
   PubMedGoogle Scholar
• Ratanavongsiri J, Sriwanthana B, Ubol S, Phanuphak P. Cell-mediated immune response following intracutaneous immunisation with human diploid cell rabies vaccine. Asian Pac J Allergy Immunol 1985;3:187-90
   PubMed Web of Science ®Google Scholar
• Jaijaroensup W, Limusanno S, Khawplod P, et al. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med 1999;6(4):234-7
   PubMed Web of Science ®Google Scholar
• Sudarshan MK, Gangaboraiah B, Ravish HS, Narayana DH. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by ID route: results of a metaanalysis. Hum Vaccin 2010;6(7):562-5
   PubMed Web of Science ®Google Scholar
• Shantavasinkul P, Tantawichien T, Wilde H, et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010;50(1):56-60
   PubMed Web of Science ®Google Scholar
• Jaiiaroensup W, Lang J, Thipkong P, et al. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. Vaccine 1998;16(16):1559-62
   PubMed Web of Science ®Google Scholar
• Immunogenicity and safety study of a new chromatographically purified Vero cell rabies vaccine with ID regimen and ERIG. Available from: http://clinicaltrials.gov/show/NCT01137045
   Google Scholar
• Immune response in adults to PrEP and simulated booster PEP with a new CPRV. Available from: http://clinicaltrials.gov/show/NCT01603875
   Google Scholar